4.3 Review

Platelet serotonin modulates immune functions

Journal

HAMOSTASEOLOGIE
Volume 36, Issue 1, Pages 11-16

Publisher

SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
DOI: 10.5482/HAMO-14-11-0073

Keywords

Inflammatory mediators; platelet immunology; leukocyte function; leukocyte activation

Categories

Ask authors/readers for more resources

This short review addresses immune functions of platelet serotonin. Platelets transport serotonin at a high concentration in dense granules and release it upon activation. Besides haemostatic, vasotonic and developmental modulation, serotonin also influences a variety of immune functions (mediated by different serotonin receptors). First, platelet serotonergic effects are directed against invading pathogens via activation and proliferation of lymphocytes, modulation of cytokine release, and recruitment of neutrophils to sites of acute inflammation by induction of selectin expression on endothelial cells. Second, serotonin levels are elevated in autoimmune diseases, such as asthma or rheumatoid arthritis, and during tissue regeneration after ischemia of myocardium or brain. Specific antagonism of serotonin receptors appears to improve survival after myocardial infarction or sepsis and to attenuate asthmatic attacks in animal models. It will be of great clinical relevance if these findings can be translated into human applications. In conclusion, targeting immune modulatory effects of platelet serotonin may provide novel therapeutic options for common health problems.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany

Peter Stachon, Klaus Kaier, Philip Hehn, Alexander Peikert, Dennis Wolf, Vera Oettinger, Dawid Staudacher, Daniel Duerschmied, Andreas Zirlik, Manfred Zehender, Christoph Bode, Constantin von zur Muehlen

Summary: In a nationwide registry study in Germany, left main stenting was found to be a safe and effective treatment option for chronic coronary syndrome patients with left main coronary artery disease, showing reduced risks of bleeding, prolonged ventilation time, and postoperative delirium after risk adjustment, along with shorter hospital stay and lower costs.

CLINICAL RESEARCH IN CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities

Marina Rieder, Nadine Gauchel, Klaus Kaier, Carolin Jakob, Stefan Borgmann, Annika Y. Classen, Jochen Schneider, Lukas Eberwein, Martin Lablans, Maria Ruethrich, Sebastian Dolff, Kai Wille, Martina Haselberger, Hanno Heuzeroth, Christoph Bode, Constantin von Zur Muehlen, Siegbert Rieg, Daniel Duerschmied

Summary: The presence of pre-existing oral anticoagulation (OAC) in COVID-19 patients has been shown to have a protective influence on mortality and recovery rates, as well as reduce the frequency of thrombotic events. This effect is independent of the anticoagulation regime during hospital stay and the stage of disease.

CLINICAL RESEARCH IN CARDIOLOGY (2022)

Article Immunology

Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients

Juliana de Castilhos, Eli Zamir, Theresa Hippchen, Roman Rohrbach, Sabine Schmidt, Silvana Hengler, Hanna Schumacher, Melanie Neubauer, Sabrina Kunz, Tonia Mueller-Esch, Andreas Hiergeist, Andre Gessner, Dina Khalid, Rogier Gaiser, Nyssa Cullin, Stamatia M. Papagiannarou, Bettina Beuthien-Baumann, Alwin Kraemer, Ralf Bartenschlager, Dirk Jaeger, Michael Mueller, Felix Herth, Daniel Duerschmied, Jochen Schneider, Roland M. Schmid, Johann F. Eberhardt, Yascha Khodamoradi, Maria J. G. T. Vehreschild, Andreas Teufel, Matthias P. Ebert, Peter Hau, Bernd Salzberger, Paul Schnitzler, Hendrik Poeck, Eran Elinav, Uta Merle, Christoph K. Stein-Thoeringer

Summary: The study found that severe cases of COVID-19 can lead to dysbiotic microbial configurations in the oropharyngeal microbiome, particularly in patients treated with broad-spectrum antibiotics, receiving invasive mechanical ventilation, or with prolonged hospitalization. Early specimen collection allowed for the prediction of COVID-19 mortality using machine learning models, with taxonomic signatures outperforming models based on clinical variables, with Neisseria and Haemophilus species abundances being the most important features.

CLINICAL INFECTIOUS DISEASES (2022)

Article Hematology

Peripheral serotonin lacks effects on endothelial adhesion molecule expression in acute inflammation

Maximilian Mauler, Nancy Schanze, Krystin Krauel, Claudia Schoenichen, Franziska Glatzki, Susanna Poeschl, Daniela Stallmann, Julius Mezger, Nadine Gauchel, Diana Sharipova, Marina Rieder, Ingo Hilgendorf, Thilo Witsch, Christoph Bode, Daniel Duerschmied

Summary: Peripheral serotonin seems to have no effect on endothelial adhesion molecule expression, despite its influence on neutrophil function. The inflammatory release of peripheral serotonin appears to be unnecessary for regulating endothelial adhesion molecules.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Cardiac & Cardiovascular Systems

Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease

Nadine Gauchel, Marina Rieder, Krystin Krauel, Isabella Goller, Maren Jeserich, Ulrich Salzer, Ana Cecilia Venhoff, Niklas Baldus, Luisa Pollmeier, Luisa Wirth, Winfried Kern, Siegbert Rieg, Hans-Jorg Busch, Maike Hofmann, Christoph Bode, Daniel Duerschmied, Achim Lother, Lukas A. Heger

Summary: This study compared the levels of complement system components in COVID-19 patients and other groups, revealing that COVID-19 patients had significantly elevated levels of CS components 5a and 4, increased levels of vWF antigen, and a significant correlation with vWF antigen, suggesting a pronounced immune inflammatory response in COVID-19 disease.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

Article Cardiac & Cardiovascular Systems

Case Report: Transient Increase of CMR T1 Mapping Indices in a Patient With COVID-19 mRNA Vaccine Induced Acute Myocarditis

Uzair Ansari, Simone Britsch, Sebastian Rogowski, Daniel Duerschmied, Theano Papavassiliu

Summary: We present a case of acute myocarditis reported after COVID-19 vaccination. CMR is useful for diagnosis and follow-up of myocarditis patients.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Review Hematology

Platelets in Myocardial Ischemia/Reperfusion Injury

Nancy Schanze, Muataz Ali Hamad, Thomas Georg Nuehrenberg, Christoph Bode, Daniel Duerschmied

Summary: Coronary artery disease is a leading cause of global mortality, with ischemia/reperfusion injury (IRI) contributing to cardiac damage. Platelets play an important role in IRI through activation and interaction with other cells. Understanding platelet contributions to IRI is crucial for developing effective treatment strategies.

HAMOSTASEOLOGIE (2023)

Article Biochemistry & Molecular Biology

Functional Characterization of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells

Xuehui Fan, Lukas Cyganek, Katja Nitschke, Stefanie Uhlig, Philipp Nuhn, Karen Bieback, Daniel Duerschmied, Ibrahim El-Battrawy, Xiaobo Zhou, Ibrahim Akin

Summary: This study compared the electrophysiological and functional properties of endothelial cells derived from human induced pluripotent stem cells with primary human cardiac microvascular endothelial cells. The results demonstrated that the two types of endothelial cells were similar in terms of ion channel function, membrane receptor signaling, and physiological cell functions, although some differences were observed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

Diagnostic Value of sST2, VCAM-1, and Adiponectin in Patients with Breast Cancer to Predict Anti-Tumour Treatment-Related Cardiac Events: A Pilot Study

Stephanie Luise Rosenkaimer, Laura Winter, Tina Sieburg, Sandra Maier, Athanasios Mavratzas, Wolf-Karsten Hofmann, Ibrahim Akin, Daniel Duerschmied, Ralf-Dieter Hofheinz, Anna Hohneck

Summary: This exploratory study investigated the diagnostic value of inflammatory markers in predicting anti-tumour treatment-related cardiac events in patients with breast cancer. The results showed that markers such as VCAM-1 and sST2 were associated with an increased likelihood of treatment-related events, providing potential for better identification of high-risk patients.

ONCOLOGY RESEARCH AND TREATMENT (2022)

Article Hematology

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Barco, Davide Voci, Ulrike Held, Tim Sebastian, Roland Bingisser, Giuseppe Colucci, Daniel Duerschmied, Andre Frenk, Bernhard Gerber, Andrea Goetschi, Stavros Konstantinides, Francois Mach, Helia Robert-Ebadi, Thomas Rosemann, Noemi R. Simon, Herve Spechbach, David Spirk, Stefan Stortecky, Lukas Vaisnora, Marc Righini, Nils Kucher

Summary: This study aimed to investigate whether thromboprophylaxis with enoxaparin would prevent hospitalization and death in symptomatic COVID-19 outpatients. The results showed that enoxaparin did not reduce the risk of hospitalization and death among these patients.

LANCET HAEMATOLOGY (2022)

Article Medicine, General & Internal

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Diona Gjermeni, Hannah Vetter, Sofia Szabo, Viktoria Anfang, Stefan Leggewie, David Hesselbarth, Daniel Duerschmied, Dietmar Trenk, Christoph B. Olivier

Summary: This study compared the performance of multiple platelet aggregometry (MEA) and thrombelastography (TEG) in detecting high on-clopidogrel platelet reactivity (HPR) in patients with atrial fibrillation (AF) and indication for oral anticoagulation (OAC) after percutaneous coronary intervention (PCI). The results showed that TEG detected higher rates of HPR compared to MEA. Conventional cut-off values for HPR may need to be re-evaluated for this high-risk population. Further studies are needed to assess the association with outcomes.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2

Anna C. Mavromanoli, Stefano Barco, Walter Ageno, Helene Bouvaist, Marianne Brodmann, Claudio Cuccia, Francis Couturaud, Claudia Dellas, Konstantinos Dimopoulos, Daniel Duerschmied, Klaus Empen, Pompilio Faggiano, Emile Ferrari, Nazzareno Galie, Marcello Galvani, Alexandre Ghuysen, George Giannakoulas, Menno Huisman, David Jimenez, Matija Kozak, Irene M. Lang, Nicolas Meneveau, Thomas Muenzel, Massimiliano Palazzini, Antoniu Octavian Petris, Giancarlo Piovaccari, Aldo Salvi, Sebastian Schellong, Kai-Helge Schmidt, Franck Verschuren, Irene Schmidtmann, Gerrit Toenges, Frederikus A. Klok, Stavros Konstantinides

Summary: This study analyzed the changes in RV function in patients with intermediate-risk PE who were switched early to oral anticoagulation. The results showed that the majority of patients had normalized RV function within 6 days and maintained normal RV function throughout the first 6 months. However, almost one in four patients continued to have evidence of RV dysfunction over the long term.

CLINICAL RESEARCH IN CARDIOLOGY (2023)

Article Hematology

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial

Davide Voci, Andrea Gotschi, Ulrike Held, Roland Bingisser, Giuseppe Colucci, Daniel Duerschmied, Riccardo M. Fumagalli, Bernhard Gerber, Barbara Hasse, Dagmar I. Keller, Stavros V. Konstantinides, Francois Mach, Silvana K. Rampini, Marc Righini, Helia Robert-Ebadi, Thomas Rosemann, Stephanie Roth-Zetzsche, Tim Sebastian, Noemi R. Simon, David Spirk, Stefan Stortecky, Lukas Vaisnora, Nils Kucher, Stefano Barco

Summary: The benefits of early thromboprophylaxis in symptomatic COVID-19 outpatients remain unclear. This study presents the 90-day results from the OVID phase III trial, which showed that early thromboprophylaxis with enoxaparin did not improve the course of COVID-19 in terms of hospitalization, death, or resolution of symptoms.

THROMBOSIS RESEARCH (2023)

Review Virology

Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment

Aydin Huseynov, Ibrahim Akin, Daniel Duerschmied, Ruediger E. Scharf

Summary: An increasing number of post-COVID patients are experiencing long-term complications from the acute COVID-19 infection, posing ongoing challenges for healthcare professionals. It has become clear that COVID-19 not only affects the respiratory system but also other organs, including the cardiovascular system. Cardiopulmonary symptoms such as shortness of breath, palpitations, limited physical capacity, and cardiac arrhythmias can persist in a significant proportion of recovered patients. This article reviews the prevalence and underlying mechanisms of COVID-19-associated arrhythmias and discusses the clinical management of various rhythm disorders in post-COVID patients.

VIRUSES-BASEL (2023)

Article Hematology

Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet function

Marina Rieder, Niklas Baldus, Daniela Stallmann, Maren Jeserich, Isabella Goller, Luisa Wirth, Luisa Pollmeier, Maike Hofmann, Christoph Bode, Hans-Joerg Busch, Bonaventura Schmid, Nadine Gauchel, Rudiger E. Scharf, Daniel Duerschmied, Achim Lother, Krystin Krauel

Summary: This study aimed to assess platelet reactivity in patients with moderate COVID-19 at early stages. Platelet reactivity was evaluated using whole-blood impedance aggregometry and flow cytometry in 20 COVID-19-positive patients, 55 COVID-19-negative patients (as patient controls), and 15 healthy individuals.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

No Data Available